TrialCancer immunology, immunotherapy : CII2026

A phase 2 study of orally administered live biotherapeutic salmonella-IL2 with FOLFIRINOX for stage IV pancreatic cancer.

Gerald Batist et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.